TRV GP Iv, LLC, 10% Owner at Tango Therapeutics, Inc. (TNGX), sold 815,824 shares at $7.04 ($5.7M) on 2025-09-08, disclosed to the SEC on 2025-09-09.
Open-market sale of $5.7M TNGX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.00 | 642,906 | $4.5M | 78.7% |
| 2 | $7.04 | 86,459 | $609K | 10.6% |
| 3 | $7.04 | 86,459 | $609K | 10.6% |
| Total | $7.01 avg | 815,824 | $5.7M | 100% |
| Filing → |
| TNGX | SELL | 2025-09-17 | $5.1M | — | Filing → |
| TNGX | SELL | 2024-09-17 | $710K | — | Filing → |
| TNGX | SELL | 2024-09-09 | $867K | — | Filing → |